Literature DB >> 32847860

The Dynamic Interface of Viruses with STATs.

Angela R Harrison1, Gregory W Moseley2.   

Abstract

Viruses commonly antagonize the antiviral type I interferon response by targeting signal transducer and activator of transcription 1 (STAT1) and STAT2, key mediators of interferon signaling. Other STAT family members mediate signaling by diverse cytokines important to infection, but their relationship with viruses is more complex. Importantly, virus-STAT interaction can be antagonistic or stimulatory depending on diverse viral and cellular factors. While STAT antagonism can suppress immune pathways, many viruses promote activation of specific STATs to support viral gene expression and/or produce cellular conditions conducive to infection. It is also becoming increasingly clear that viruses can hijack noncanonical STAT functions to benefit infection. For a number of viruses, STAT function is dynamically modulated through infection as requirements for replication change. Given the critical role of STATs in infection by diverse viruses, the virus-STAT interface is an attractive target for the development of antivirals and live-attenuated viral vaccines. Here, we review current understanding of the complex and dynamic virus-STAT interface and discuss how this relationship might be harnessed for medical applications.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  STAT signaling; STAT transcription factors; host-pathogen interactions; immune evasion; virus-host interactions

Mesh:

Substances:

Year:  2020        PMID: 32847860      PMCID: PMC7592203          DOI: 10.1128/JVI.00856-20

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  272 in total

1.  Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1.

Authors:  St Patrick Reid; Charalampos Valmas; Osvaldo Martinez; Freddy Mauricio Sanchez; Christopher F Basler
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

2.  Human metapneumovirus inhibits the IL-6-induced JAK/STAT3 signalling cascade in airway epithelium.

Authors:  Dana N Mitzel; Richard J Jaramillo; Heather Stout-Delgado; Albert P Senft; Kevin S Harrod
Journal:  J Gen Virol       Date:  2013-10-10       Impact factor: 3.891

3.  Zika virus inhibits type-I interferon production and downstream signaling.

Authors:  Anil Kumar; Shangmei Hou; Adriana M Airo; Daniel Limonta; Valeria Mancinelli; William Branton; Christopher Power; Tom C Hobman
Journal:  EMBO Rep       Date:  2016-10-24       Impact factor: 8.807

4.  HTLV-1 p12(I) protein enhances STAT5 activation and decreases the interleukin-2 requirement for proliferation of primary human peripheral blood mononuclear cells.

Authors:  C Nicot; J C Mulloy; M G Ferrari; J M Johnson; K Fu; R Fukumoto; R Trovato; J Fullen; W J Leonard; G Franchini
Journal:  Blood       Date:  2001-08-01       Impact factor: 22.113

5.  IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines.

Authors:  Lorand L Kis; Miki Takahara; Noemi Nagy; George Klein; Eva Klein
Journal:  Blood       Date:  2005-12-06       Impact factor: 22.113

6.  Adenovirus sequesters phosphorylated STAT1 at viral replication centers and inhibits STAT dephosphorylation.

Authors:  Sook-Young Sohn; Patrick Hearing
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

7.  Infection-triggered regulatory mechanisms override the role of STAT 4 in control of the immune response to influenza virus antigens.

Authors:  A Bot; E Rodrigo; T Wolfe; S Bot; M G Von Herrath
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

8.  Unphosphorylated STAT6 contributes to constitutive cyclooxygenase-2 expression in human non-small cell lung cancer.

Authors:  X Cui; L Zhang; J Luo; A Rajasekaran; S Hazra; N Cacalano; S M Dubinett
Journal:  Oncogene       Date:  2007-01-22       Impact factor: 9.867

9.  HCMV activates the IL-6-JAK-STAT3 axis in HepG2 cells and primary human hepatocytes.

Authors:  Quentin Lepiller; Wasim Abbas; Amit Kumar; Manoj K Tripathy; Georges Herbein
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

10.  JAK2 Inhibition Impairs Proliferation and Sensitises Cervical Cancer Cells to Cisplatin-Induced Cell Death.

Authors:  Ethan L Morgan; Andrew Macdonald
Journal:  Cancers (Basel)       Date:  2019-12-04       Impact factor: 6.639

View more
  10 in total

1.  Molecular Basis of Functional Effects of Phosphorylation of the C-Terminal Domain of the Rabies Virus P Protein.

Authors:  Jingyu Zhan; Ericka Watts; Aaron M Brice; Riley D Metcalfe; Ashley M Rozario; Ashish Sethi; Fei Yan; Toby D M Bell; Michael D W Griffin; Gregory W Moseley; Paul R Gooley
Journal:  J Virol       Date:  2022-04-11       Impact factor: 6.549

2.  Accelerated T-cell exhaustion: its pathogenesis and potentially severe outcomes.

Authors:  Kevin Roe
Journal:  Hum Cell       Date:  2022-10-24       Impact factor: 4.374

3.  Deactivation of the antiviral state by rabies virus through targeting and accumulation of persistently phosphorylated STAT1.

Authors:  Gayathri Manokaran; Michelle D Audsley; Haruka Funakoda; Cassandra T David; Katherine A Garnham; Stephen M Rawlinson; Celine Deffrasnes; Naoto Ito; Gregory W Moseley
Journal:  PLoS Pathog       Date:  2022-05-16       Impact factor: 7.464

Review 4.  Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling Pathways.

Authors:  Candice Mazewski; Ricardo E Perez; Eleanor N Fish; Leonidas C Platanias
Journal:  Front Immunol       Date:  2020-11-23       Impact factor: 7.561

Review 5.  JAK-STAT Pathway: A Novel Target to Tackle Viral Infections.

Authors:  Ifeanyi Jude Ezeonwumelu; Edurne Garcia-Vidal; Ester Ballana
Journal:  Viruses       Date:  2021-11-27       Impact factor: 5.048

6.  Poxviruses and paramyxoviruses use a conserved mechanism of STAT1 antagonism to inhibit interferon signaling.

Authors:  Callum Talbot-Cooper; Teodors Pantelejevs; John P Shannon; Christian R Cherry; Marcus T Au; Marko Hyvönen; Heather D Hickman; Geoffrey L Smith
Journal:  Cell Host Microbe       Date:  2022-02-18       Impact factor: 21.023

7.  Innate immune regulation in HIV latency models.

Authors:  Rebecca M Olson; Germán Gornalusse; Leanne S Whitmore; Dan Newhouse; Jennifer Tisoncik-Go; Elise Smith; Christina Ochsenbauer; Florian Hladik; Michael Gale
Journal:  Retrovirology       Date:  2022-07-08       Impact factor: 3.768

8.  Phenotypic Divergence of P Proteins of Australian Bat Lyssavirus Lineages Circulating in Microbats and Flying Foxes.

Authors:  Celine Deffrasnes; Meng-Xiao Luo; Linda Wiltzer-Bach; Cassandra T David; Kim G Lieu; Lin-Fa Wang; David A Jans; Glenn A Marsh; Gregory W Moseley
Journal:  Viruses       Date:  2021-05-04       Impact factor: 5.048

Review 9.  Evolutionary history of cotranscriptional editing in the paramyxoviral phosphoprotein gene.

Authors:  Jordan Douglas; Alexei J Drummond; Richard L Kingston
Journal:  Virus Evol       Date:  2021-03-27

10.  Definition of the immune evasion-replication interface of rabies virus P protein.

Authors:  Jingyu Zhan; Angela R Harrison; Stephanie Portelli; Thanh Binh Nguyen; Isshu Kojima; Siqiong Zheng; Fei Yan; Tatsunori Masatani; Stephen M Rawlinson; Ashish Sethi; Naoto Ito; David B Ascher; Gregory W Moseley; Paul R Gooley
Journal:  PLoS Pathog       Date:  2021-07-08       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.